Evidence map›Paper›PMID 40979100›Full record

ArticleJournal of clinical and translational science2025

Neighborhood characteristics of expanded access patients at an academic referral center.

Misty Gravelin, Jeanne Wright, Adrian Weyhing, Vikas Kotagal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Misty GravelinMichigan Investigator Assistance Program, University of Michigan, Ann Arbor, MI, USA.
Jeanne WrightMichigan Investigator Assistance Program, University of Michigan, Ann Arbor, MI, USA.
Adrian WeyhingUniversity of Michigan, Precision Health Initiative, Ann Arbor, MI, USA.
Vikas KotagalMichigan Investigator Assistance Program, University of Michigan, Ann Arbor, MI, USA.ORCID https://orcid.org/0000-0001-5110-9303

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expanded access (EA) is a United States regulatory approach for the use of investigational drugs/devices that do not yet have conventional approval, in clinical care contexts. We conducted a retrospective study to analyze the neighborhood characteristics of patients who have received EA treatments at our academic medical center between 2018 and 2023. EA patient neighborhoods showed lower median family income, lower proportion of bachelor's degree graduates, and a higher proportion of people identifying as non-Hispanic White ethnicity compared to the surrounding (Washtenaw) county. These differences may underly differential interest in EA treatments or may point to disparities in access to evidence-based care.

Indexed as

Expanded accesshealth services accessibilityMichiganresidence characteristicsUnited states food and drug administration

Identifiers

PMID40979100
PMCPMC12444704

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.